← Back to Search

Educational Video for Cancer Understanding

N/A

Recruiting

Led By Daniel G Stover, MD

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be >= 18 years of age

Be undergoing clinical tumor or circulating tumor deoxyribonucleic acid (DNA) NGS

Must not have

Exclude patients who are not English- or Spanish-speaking

Timeline

Screening 3 weeks

Treatment Varies

Follow Up immediately before and immediately after video intervention

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether a video can help patients understand genomic testing for metastatic cancer. Results may help doctors provide better patient care by communicating the importance of this type of testing.

Who is the study for?

This trial is for adults over 18 with metastatic cancer who are undergoing tumor DNA sequencing. It's designed to see if a video can help them understand their genomic testing better. Participants must speak English or Spanish, and have confirmed biopsy results.

What is being tested?

The study is evaluating the effectiveness of an educational video intervention on patients' comprehension of tumor genomic testing. The goal is to determine if this approach can enhance patient-centered care by improving communication about genomic tests.

What are the potential side effects?

Since the interventions include health education and questionnaire administration, there are no direct medical side effects associated with typical drugs or treatments; however, participants may experience stress or anxiety related to learning about their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am currently having genetic testing on my cancer.

Select...

My cancer has spread, confirmed by a biopsy.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ immediately before and immediately after video intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~immediately before and immediately after video intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately before and immediately after video intervention for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Message-specific knowledge/recall accuracy

Secondary study objectives

Change in patient genomic knowledge

Change in patient genomic knowledge in metastatic breast cancer (MBC) versus metastatic lung cancer (MLC) patients

Change in patient trust of physician/provider

+1 more

Side effects data

From 2020 Phase 3 trial • 177 Patients • NCT01817075

13%

Rash maculo-papular

10%

Skin and subcutaneous tissue disorders - Other, specify

Mucositis oral

Sepsis

Skin ulceration

Urticaria

100%

80%

60%

40%

20%

Study treatment Arm

Arm I (CHG Cleansing Wipe)

Arm II (Control)

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Health services research (video)Experimental Treatment2 Interventions

Patients participate in a video intervention session and complete questionnaires at baseline, after participating in the video intervention, and after receiving NGS results.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Health Education

2014

Completed Phase 3

~4410

0 / 4Eligibility criteria met